Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.33 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | TLR4 | O00206 | 1/20 | 0.34 |
| ▸ | CD14 | P08571 | 1/20 | 0.34 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | DHPS | P49366 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17156891 | 1.00 | MEN1 (0.40) | MEN1KMT2AALDH1A1NOS3NOS1 | |
| SCHEMBL2730996 | 0.98 | MEN1 (0.41) | MEN1KMT2AALDH1A1NOS3NOS1 | |
| SCHEMBL4111817 | 0.98 | MEN1 (0.41) | MEN1KMT2AALDH1A1NOS3NOS1 | |
| Water SCHEMBL3262698 | 0.96 | MEN1 (0.40) | MEN1KMT2AALDH1A1NOS3NOS1 | |
| Hydrochloric Acid SCHEMBL28648293 | 0.96 | MEN1 (0.43) | MEN1KMT2AALDH1A1NOS3NOS1 | |
| SCHEMBL1427854 | 0.93 | — | — | |
| Sulfuric Acid SCHEMBL11367009 | 0.83 | NPSR1 (0.49) | MEN1KMT2AALDH1A1NOS3NOS1 | |
| SCHEMBL6938637 | 0.80 | NOS1 (0.37) | MEN1KMT2ANOS3NOS1NOS2 | |
| SCHEMBL4103964 | 0.80 | MEN1 (0.52) | MEN1KMT2APRSS1PRSS2PRSS3 | |
| SCHEMBL4094464 | 0.80 | NOS1 (0.37) | MEN1KMT2ANOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210220295-A1 | TREATMENT OF CANCER BY GUANIDINIUM DERIVATIVES | UCAR HEALTH GMBH (DE) | 2021-07-22 | — | — | US | claimed |
| CN-111345308-A | Preparation for strongly removing vibrios and preparation method thereof | 江苏众乐生物科技股份有限公司 | 2020-06-30 | — | — | CN | claimed |
| US-20130315982-A1 | LIPOSOMAL DRUG COMPOSITION CONTAINING A POLYMERIC GUANIDINE DERIVATIVE | MINDINVEST HOLDINGS LTD. (MT) | 2013-11-28 | — | — | US | claimed |
| EP-2632435-A1 | LIPOSOMAL DRUG COMPOSITION CONTAINING A POLYMERIC GUANIDINE DERIVATIVE | Mindinvest Holdings Ltd. (MT) | 2013-09-04 | — | — | EP | claimed |
| US-20130040388-A1 | CYTOSTATIC DRUG COMPOSITION | SCHMIDT OSKAR (AT) | 2013-02-14 | — | — | US | claimed |
| US-8198333-B2 | Cytostatic drug composition | GEOPHARMA PRODUKTIONS GMBH (AT) | 2012-06-12 | — | — | US | claimed |
| WO-2012055568-A1 | LIPOSOMAL DRUG COMPOSITION CONTAINING A POLYMERIC GUANIDINE DERIVATIVE | MINDINVEST HOLDINGS LTD. (MT) | 2012-05-03 | — | — | WO | claimed |
| US-20110076766-A1 | Cytostatic Drug Composition | SCHMIDT OSKAR | 2011-03-31 | — | — | US | claimed |
| US-7820719-B2 | Cytostatic drug composition | GEOPHARMA PRODUKTIONS GMBH (AT) | 2010-10-26 | — | — | US | claimed |
| EP-1734064-B1 | Polymer guanidine derivatives as a cytostatic medicament | GEOPHARMA PRODUKTIONSGMBH (AT) | 2008-08-06 | — | — | EP | claimed |
| EP-1605927-B1 | ANTI-MICROBIALLY ACTIVE DIAMINE-BASED GUANINE DERIVATIVES | GEOPHARMA PRODUKTIONSGMBH (AT) | 2008-01-09 | — | — | EP | claimed |
| WO-2007101445-A1 | BIOCIDAL CLEANING COMPOSITIONS | GLAD, THOMAS CHRISTIAN (DK) | 2007-09-13 | — | — | WO | claimed |
| US-20060093573-A1 | Drug composition with antimicrobial activity | GEOPHARMA PRODUKTIONS GMBH (AT) | 2006-05-04 | — | — | US | claimed |
| US-20060034795-A1 | Cytostatic drug composition | GEOPHARMA PRODUKTIONS GMBH (AT) | 2006-02-16 | — | — | US | claimed |
| US-20220193468-A1 | FIBRE FILTER AND METHOD OF MANUFACTURE THEREOF | OWNERS CAPITAL GMBH (DE) | 2022-06-23 | — | — | US | disclosed |
| US-20210220295-A1 | TREATMENT OF CANCER BY GUANIDINIUM DERIVATIVES | UCAR HEALTH GMBH (DE) | 2021-07-22 | — | — | US | disclosed |
| CN-107809908-B | Aqueous antimicrobial film-forming composition for teat treatment by spray application | 艺康美国股份有限公司 | 2021-04-13 | — | — | CN | disclosed |
| WO-2007101445-A1 | BIOCIDAL CLEANING COMPOSITIONS | GLAD, THOMAS CHRISTIAN (DK) | 2007-09-13 | — | — | WO | disclosed |
| US-20060093573-A1 | Drug composition with antimicrobial activity | GEOPHARMA PRODUKTIONS GMBH (AT) | 2006-05-04 | — | — | US | disclosed |
| US-20060034795-A1 | Cytostatic drug composition | GEOPHARMA PRODUKTIONS GMBH (AT) | 2006-02-16 | — | — | US | disclosed |